These projects were made possible from Cure Alzheimer's Fund support.
Project Description | Researchers | Funding |
---|---|---|
Preclinical Analysis of Synaptogyrin-3 Oligonucleotides to Target Tauopathy |
2024 $201,250 |
|
Targeting Tauopathies With Antisense Oligonucleotides to Synaptogyrin-3 |
2021, 2022 $345,000 |
These published papers resulted from Cure Alzheimer’s Fund support.
Nachman, E., & Verstreken, P. Synaptic proteostasis in Parkinson’s disease, Current Opinion in Neurobiology, February 1, 2022, Read More
Decet, M., & Verstreken, P. Presynaptic Autophagy and the Connection With Neurotransmission, Frontiers in Cell and Developmental Biology, December 17, 2021, Read More